Barinthus Biotherapeutics plc. - American Depositary Shares, each representing one ordinary share (BRNS)

CUSIP: 91864C107

Q1 2024 13F Holders as of 31 Mar 2024

Type / Class
Equity / American Depositary Shares, each representing one ordinary share
Shares outstanding
40,291,821
Total 13F shares
9,698,209
Share change
-19,926
Total reported value
$21,348,890
Price per share
$2.38
Number of holders
15
Value change
-$47,421
Number of buys
1
Number of sells
3

Quarterly Holders Quick Answers

What is CUSIP 91864C107?
CUSIP 91864C107 identifies BRNS - Barinthus Biotherapeutics plc. - American Depositary Shares, each representing one ordinary share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Barinthus Biotherapeutics plc. - American Depositary Shares, each representing one ordinary share (BRNS) as of Q1 2024

As of 31 Mar 2024, Barinthus Biotherapeutics plc. - American Depositary Shares, each representing one ordinary share (BRNS) was held by 15 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 9,698,209 shares. The largest 10 holders included M&G Plc, Alphabet Inc., HSG Holding Ltd, DC Funds, LP, BlueCrest Capital Management Ltd, Baird Financial Group, Inc., Johns Hopkins University, RENAISSANCE TECHNOLOGIES LLC, Ipswich Investment Management Co., Inc., and Janney Montgomery Scott LLC. This page lists 15 institutional shareholders reporting positions in this security for the Q1 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.